Merck Research Laboratories Ventures Fund

MRL Ventures Fund (MRLV) is the therapeutics-focused corporate venture capital arm of Merck & Co., known as MSD outside the United States and Canada. Based in Cambridge, Massachusetts, the fund invests globally in early-stage biomedical companies that are developing transformative medicines. MRLV is stage-agnostic but primarily focuses on seed and Series A investments where innovative science and novel therapeutic modalities can address significant unmet medical needs. The fund's investment team consists of experienced drug hunters and venture capitalists who provide strategic oversight and access to the broader Merck Research Laboratories network. MRLV's portfolio spans diverse therapeutic areas, including oncology, immunology, neuroscience, and metabolic diseases. By bridging the gap between academic innovation and industrial drug development, MRLV plays a critical role in the biotech ecosystem.